Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be able to understand the study and be willing to sign a consent form agreeing to take part.
- You must be between 40 and 80 years old (male or female).
- You must have a diagnosis of Parkinson's disease, either confirmed using a specific standard set of criteria (UK Parkinson's Disease Society Brain Bank criteria), or a documented diagnosis along with a specific type of brain implant device (called a Percept RC deep brain stimulator) placed in one of two particular areas of the brain.
- You must be willing to follow the sleep study schedule, which includes turning off your brain stimulator device for one night.
- You must score 23 or higher on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA).
- You must be willing to stop taking any sleep medications (such as benzodiazepines or Ambien) for at least 3 days before the study.
Who may not be able to join:
- People with a history of serious heart or cardiovascular disease, or untreated sleep apnea (a condition where breathing repeatedly stops during sleep).
- People with other neurological conditions affecting the brain or nervous system, such as stroke, multiple sclerosis, brain tumors, ALS, or muscle diseases like muscular dystrophy or myopathy.
- People who have been diagnosed with dementia.
- People who have changed their Parkinson's medication in the past month.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Eleni O Vaou, MD, The University of Texas Health Science Center at San Antonio
Phone: 210 450 8048
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sensing & Sleep: Parkinson's Disease Sleep Assessment; Motor severity; Epworth Sleepiness Scale (ESS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.